Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1373056 | Bioorganic & Medicinal Chemistry Letters | 2008 | 6 Pages |
A series of OX2R/OX1R dual orexin antagonists was prepared based on a proline bis-amide identified as a screening lead. Through a combination of classical and library synthesis, potency enhancing replacements for both amide portions were discovered. N-methylation of the benzimidazole moiety within the lead structure significantly reduced P-gp susceptibility while increasing potency, giving rise to good brain penetration. A compound from this series has demonstrated in vivo central activity when dosed peripherally in a pharmacodynamic model of orexin activity.
Graphical abstractA series of potent dual orexin antagonists was prepared based on a proline bis-amide core that demonstrate in vivo central activity in a pharmacodyamic model of orexin activity.Figure optionsDownload full-size imageDownload as PowerPoint slide